A case of acute myocarditis induced by PD-1 inhibitor (sintilimab) in the treatment of large cell neuroendocrine carcinoma.

Zheng, Siming; Zhang, Haiyu; Hu, Bingshuang; Zhou, Jiaxiong; Wen, Lei; Li, Minying

Zheng, Siming; Zhang, Haiyu; Hu, Bingshuang; Zhou, Jiaxiong; Wen, Lei; Li, Minying.

Afiliação

Zheng S; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.
Zhang H; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.
Hu B; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.
Zhou J; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.
Wen L; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.
Li M; Second Department of Radiotherapy, Zhongshan People's Hospital (Zhongshan Hospital of Sun Yat-Sen University), Zhongshan, Guangdong 528400, China.

Heliyon ; 9(6): e16874, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37342584

Palavras-chave

Immune checkpoint inhibitors (ICIs); Immune-related adverse events (irAEs); Myocarditis large cell neuroendocrine carcinoma (LCNEC); Sintilimab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article